Epidemiology of anaphylaxis

被引:65
作者
Lieberman, Phil [1 ,2 ]
机构
[1] Univ Tennessee, Coll Med, Dept Med, Div Allergy & Immunol, Germantown, TN 38138 USA
[2] Univ Tennessee, Coll Med, Dept Pediat, Div Allergy & Immunol, Germantown, TN 38138 USA
关键词
anaphylaxis; drug reactions; epidemiology; food allergy;
D O I
10.1097/ACI.0b013e3283036a69
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of review The purpose of this article is not only to review the epidemiology of anaphylaxis and factors that affect the epidemiology but also to help us understand underlying mechanisms and predisposing factors. This, in turn, has a bearing on efforts related to prevention and management. Recent findings The purpose of this review is to assess the incidence of anaphylaxis and to review the factors that affect this incidence, with special reference to the most common causes, drugs and foods. Factors affecting the incidence are geographic location, sex, atopy, and socioeconomic status. Although no exact incidence, based upon available data, can be established, it is reasonable to assume that 1-2% of the population may be affected. Also, clearly, there is underreporting of episodes. Finally, the incidence of anaphylaxis appears to be increasing. Summary The exact incidence of anaphylaxis is unknown, but appears to be increasing. Foods and drugs are the most common causes. The incidence is affected by geographical location, sex, atopy, and socioeconomic factors.
引用
收藏
页码:316 / 320
页数:5
相关论文
共 46 条
[1]  
ANTHONY F, 2001, J ALLERGY CLIN IMMUN, V108, P861
[2]   The risk of anaphylactic reactions to rocuronium in the United States is comparable to that of vecuronium: An analysis of food and drug administration reporting of adverse events [J].
Bhananker, SM ;
O'Donnell, JT ;
Salemi, JR ;
Bishop, MJ .
ANESTHESIA AND ANALGESIA, 2005, 101 (03) :819-822
[3]   Further fatalities caused by anaphylactic reactions to food, 2001-2006 [J].
Bock, S. Allan ;
Munoz-Furlong, Anne ;
Sampson, Hugh A. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (04) :1016-1018
[4]   Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization [J].
Bohlke, K ;
Davis, RL ;
DeStefano, F ;
Marcy, SM ;
Braun, MM ;
Thompson, RS .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (03) :536-542
[5]   Risk of anaphylaxis after vaccination of children and adolescents [J].
Bohlke, K ;
Davis, RL ;
Marcy, SM ;
Braun, MM ;
DeStefano, F ;
Black, SB ;
Mullooly, JP ;
Thompson, RS .
PEDIATRICS, 2003, 112 (04) :815-820
[6]   Parent reported allergy and anaphylaxis in 4173 South Australian children [J].
Boros, CA ;
Kay, D ;
Gold, MS .
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2000, 36 (01) :36-40
[7]  
BUNSAWANSONG W, 2005, J ALLERGY CLIN IMMUN, V115, pS39
[8]   Regional differences in EpiPen prescriptions in the United States: The potential role of vitamin D [J].
Camargo, Carlos A., Jr. ;
Clark, Sunday ;
Kaplan, Michael S. ;
Lieberman, Philip ;
Wood, Robert A. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (01) :131-136
[9]   Anaphylaxis: a 7-year follow-up survey of 46 children [J].
Cianferoni, A ;
Novembre, E ;
Pucci, N ;
Lombardi, E ;
Bernardini, R ;
Vierucci, A .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2004, 92 (04) :464-468
[10]   Epidemiology of anaphylaxis [J].
Clark, Sunday ;
Camargo, Carlos A., Jr. .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2007, 27 (02) :145-+